Found: 6
Select item for more details and to access through your institution.
Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.996005
- By:
- Publication type:
- Article
Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies.
- Published in:
- Research in Pharmaceutical Sciences, 2020, v. 15, n. 3, p. 226, doi. 10.4103/1735-5362.288425
- By:
- Publication type:
- Article
Rapid review and meta‐analysis of adverse events associated with molnupiravir in patients with COVID‐19.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4403, doi. 10.1111/bcp.15449
- By:
- Publication type:
- Article
Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence.
- Published in:
- Immunity, Inflammation & Disease, 2022, v. 10, n. 6, p. 1, doi. 10.1002/iid3.628
- By:
- Publication type:
- Article
Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis.
- Published in:
- Immunity, Inflammation & Disease, 2021, v. 9, n. 4, p. 1197, doi. 10.1002/iid3.502
- By:
- Publication type:
- Article
In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-β inhibition.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-023-47069-w
- By:
- Publication type:
- Article